GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (348)

Latest Posts

About This Stock More About This Stock
Gilead HIV Success Seen As Bulwark Against Patent Loss, Competition
Article By: The Fly
Tuesday, May 30, 2017 7:29 PM EDT
Gilead announced Tuesday that its latest HIV treatment candidate met its primary goal in four late-stage studies, showing "non-inferiority" against existing regimens, including a competitor from GlaxoSmithKline.
In this article: GSK, GILD
Read
E Trump's Kvittle
Article By: Vivian Lewis
Tuesday, May 23, 2017 12:24 AM EDT
The President should not be blamed for all the fall in our currency, because even before he hit the scene the US$ was up way over trend, and near its 1985 peak. To revive industry, as Trump proposes, he needs a cheaper currency.
In this article: , ALV, CZZ, F, GSK, MXE, TTM, VALE, VOD, CH, ANCUF, AQUNF, BKSHF, CGRIF, CMDXF, DLKGF, NPSNY, OROCF, PPEHF, TCTZF, BLRX, SHPG, TEVA, CGEN, CUBA, INPCF, BNTC, BNTCW
Read
Global Earnings And Company News Update
Article By: Vivian Lewis
Saturday, May 13, 2017 4:31 PM EDT
This week several international companies in different sectors reported earnings as well as market moving events are covered in this weekly report.
In this article: CPA, CZZ, AZSEY, SAXPY, TEVA, CCJ, GSK, JFC, MXE, TCTZF, FCAU, BVNRY, BNS
Read
E Global Earnings Update
Article By: Vivian Lewis
Thursday, April 27, 2017 6:45 PM EDT
Earnings and more for companies in Latin America and elsewhere, plus a focus on pharma.
In this article: CX, CZZ, GSK, NOK, PBR, VALE, VR, MXCHF, OROCF, RHHBF, RHHBY Also: AZSEY, SLFPY, FBASF, FMI, VRGDF
Read
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA
Read

PARTNER HEADLINES

Latest Tweets for $GSK

No tweets yet!